Portfolio company
Smartcatch
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops microtechnology devices for isolating circulating tumour cells from blood samples to assist researchers and clinicians in cancer diagnosis and monitoring.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vortex Biotech
This company provides circulating tumour cell isolation systems for clinicians, researchers and pharmaceutical companies to support cancer diagnosis and patient monitoring.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Vortex
This company produces automated liquid biopsy systems that isolate circulating tumour cells from blood samples for researchers and clinicians in the oncology sector.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Sampling Human
This company develops single-cell analysis platforms and biocytometry kits for diagnostic, healthcare, and research organisations to improve early disease detection and treatment monitoring.
Avant Genomics
The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.
Molecular Stethoscope
This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.
PreComb
This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.
